Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-04-24

Clinical Trial Update: Evaluation and Intervention for the Effects of Osteogenesis Imperfecta

View source ↗

Summary

A NICHD-sponsored clinical trial evaluating interventions for the effects of osteogenesis imperfecta has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Conditions: Osteogenesis Imperfecta | Status: COMPLETED